North America Cancer Tissue Diagnostics Market
北美癌症组织诊断市场预计将从 2018 年的 9.2379 亿美元增至 2027 年的 15.8738 亿美元。预计该市场将以 6.5% 的复合年增长率增长2019-2027。
市场的增长是由以下因素驱动的： 北美地区癌症患病率不断上升以及新产品的发布和推广FDA 批准。然而，由于该地区缺乏癌症诊断报销政策，该市场的增长可能会放缓。
频繁的FDA批准和产品发布推动了癌症组织诊断市场的增长。大多数主要市场参与者都参与制造各种癌症诊断产品，这些产品可提供最大的优势和早期诊断。例如，2019 年 6 月，安捷伦科技公司的 PD-L1 IHC 22C3 pharmDx 检测获得美国食品和药物管理局 (FDA) 批准。该检测被批准用于识别头颈鳞状细胞癌 (HNSCC) 患者是否接受 KEYTRUDA (pembrolizumab)（默克公司生产的抗 PD-1 疗法）的治疗。此外，2018 年 3 月，安捷伦科技公司推出了一种新的免疫组织化学颜色：适用于 Dako Omnis 的 HRP Magenta。色原的最新染色特性将有助于其评估皮肤和肺组织。因此，诊断技术的不断发展以及 FDA 的批准将加速预测期内的市场增长。
美国预计由于癌症患病率不断上升、疾病诊断和治疗的改进以及市场参与者取得的进步，该公司在北美地区处于市场领先地位。此外，该国还有多家医院、超级专科医院为心血管疾病提供诊断和治疗服务。因此，考虑到上述因素，在预测期内，该国市场的增长可能会在北美地区贡献最大份额。
北美癌症组织诊断 –市场细分
按测试类型
公司简介
Strategic insights for North America Cancer Tissue Diagnostics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 923.79 Million |
| Market Size by 2027 | US$ 1,587.38 Million |
| Global CAGR (2019 - 2027) | 6.5% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By 测试类型
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Cancer Tissue Diagnostics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies
The North America Cancer Tissue Diagnostics Market is valued at US$ 923.79 Million in 2018, it is projected to reach US$ 1,587.38 Million by 2027.
As per our report North America Cancer Tissue Diagnostics Market, the market size is valued at US$ 923.79 Million in 2018, projecting it to reach US$ 1,587.38 Million by 2027. This translates to a CAGR of approximately 6.5% during the forecast period.
The North America Cancer Tissue Diagnostics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Cancer Tissue Diagnostics Market report:
The North America Cancer Tissue Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Cancer Tissue Diagnostics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Cancer Tissue Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Cancer Tissue Diagnostics Market
